Ira Shoulson, M.D.

Outstanding Leadership, Parkinson Study Group 20 Years of Service. 2006

Stanley Fahn Lecturer, Movement Disorder Society. 2006

H. Houston Merritt Lecturer, American Academy of Neurology. 2005

J.L. Silversides Lecturer, University of Toronto. 2005

Chair, Organizing Committee, Thomas N. Chase Symposium, NINDS. 2004

Co-Chair, Organizing Committee, Inaugural World Parkinson Congress. 2004 - 2006

Louis C. Lasagna Memorial Lecturer, Tufts University. 2004

Stephen J. Fink Memorial Lecturer, Boston University. 2004

Chair, Program Committee, World Congress on Huntington's Disease. 2003

Member, Scientific Advisory Board, Hereditary Disease Foundation. 2003 - 2007

Member, National Institute of Neurological Disorders and Stroke (NINDS) Advisory Council. 2002 - 2005

Principal Investigator, Prospective Huntington At Risk Observational Study, NIH (HG02449). 2002 - 2007

Scientific Advisory Board, Dystonia Medical Research Foundation. 2002 - 2006

Editorial Board, Neurology Today. 2001

Edward Fogan Lecture, University of Buffalo. 2001

Member, Science Committee, American Academy of Neurology. 2001 - 2003

America's Top Doctors (Castle Connoly/Marquis), 1st - 4th editions. 2001 - 2004

First Vice President, American Neurological Association. 2001 - 2002

President, American Society Experimental Neurotherapeutics (ASENT). 2001 - 2003

Nathan L. Cohen Neurology Resident Guest Lectureship, Johns Hopkins University. 2000

American Academy of Neurology Movement Disorder Award. 2000

Rochester Academy of Medicine Award of Merit. 2000

Editorial Committee, Disease Markers. 2000

Chair (Elected), Executive Committee, Parkinson Study Group. 2000 - 2006

University of Rochester Neurology Faculty Award. 1999

Director, Huntington's Disease Society of America/University of Rochester Center of Excellence. 1999

First John B. Penney Jr. Memorial Lecture, Massachusetts General Hospital. 1999

President-Elect, American Society Experimental Neurotherapeutics (ASENT). 1999 - 2001

Member, National Neurofibromatosis Foundation Research Advisory Board. 1998

Editorial Board, Current Treatment Options in Neurology. 1998

Guthrie Family Humanitarian Award, Huntington's Disease Society of America. 1998

First Robert S. Klayman Memorial Lecture in Parkinson's Disease Research, Washington University. 1998

Member, Scientific Advisory Board, Hereditary Disease Foundation. 1998 - 2002

Chair, Program Committee, American Society of Experimental NeuroTherapeutics (ASENT). 1997 - 1999

Secretary, American Neurological Association. 1997 - 2001

Milton Wexler Award for Huntington's Disease Research, Huntington's Disease Society of America. 1997

Representative (ANA), National Committee on Research in Neurological & Communicative Disorders & Stroke. 1997

Representative (ANA), National Foundation for Brain Research. 1997

Treasurer, Movement Disorder Society. 1997 - 1999

The Best Doctors in America: Northeast Region, Woodward/White Inc., 1st edition.. 1996 - 1997

Chair (Elected), Executive Committee, Huntington Study Group. 1996 - 2002

Expert Consultant, FDA, Special Government Employee. 1996

Associate Editor, Archives of Neurology. 1996

Member, Program Review Committee, Dana Foundation. 1995

Representative (University of Rochester), US Pharmacopeia. 1995

Member, Nominating Committee, American Neurological Association. 1994

Member, University of Rochester, Chair of Department of Psychiatry Search Committee. 1994 - 1996

Chair, Public Policy Committee, American Neurological Association. 1994 - 1997

Invited Lecturer, Sigma Tau Foundation, Lectures on Aging. 1994

Member, Research for Rett Syndrome Scientific Review Committee. 1994

Chair, Performance and Safety Monitoring Board, NINDS. 1994

Director, AAN Course. 1994 - 1998

Chair (Elected), Executive Committee, Parkinson Study Group. 1994 - 2000

Treasurer-Elect, Movement Disorder Society. 1994 - 1996

Member, International Editorial Board, CNS Drugs. 1993

Principal Investigator, The Pew-McDonnell. 1993 - 1996

Director, National Parkinson Foundation-University of Rochester Center of Excellence. 1993

Chair, Executive Committee, Huntington Study Group. 1993 - 1996

Member, Scientific Advisory Board, Hereditary Disease Foundation. 1993 - 1997

Member, American Academy of Neurology Decade of the Brain Advisory Committee. 1992 - 1994

Councilor, American Neurological Association. 1992 - 1994

Member, FDA Peripheral and Central Nervous System Advisory Committee. 1992 - 1996

Member, American Academy of Neurology, Legislative Affairs Committee. 1992

The Best Doctors in America, Woodward/White Inc. 1st, 2nd ,3rd, and 4th editions. 1992 - 1999

Co-chair, Subcommittee on Clinical Research, American Academy of Neurology. 1991 - 1992

Chair, American Neurological Association Scientific Program Advisory Committee. 1991 - 1993

Distinguished Achievement in Medicine Award, Modern Medicine. 1991

Member, Professional Advisory Board, Children with Attention Deficit Disorders (ChADD). 1991 - 1995

Robert Graves Professorship, Albany Medical College. 1991

Member, Program Committee, WFN Research Group on Huntington's Disease. 1991 - 1993

Good Housekeeping's list of The 400 Best Doctors in America. 1991

University of Rochester, Louis C. Lasagna Professor of Experimental Therapeutics, Named Chair. 1990

National Science Council, Huntington's Disease Society of America. 1990 - 1994

Scientific Advisory Council, Huntington Society of Canada. 1990

Member, NIA Clinical Trial Oversight Committee. 1990

Editorial Board, Acta Neurologica Scandinavica. 1990 - 1997

Public Policy Fellowship, Joseph P. Kennedy Jr. Foundation. 1990 - 1991

Co-Director, NIH Training Program: Experimental Therapeutics of Neurological Disorders (NS-07338). 1990

Scientific Advisory Board, Dystonia Medical Research Foundation. 1990 - 1995

Member, Phase I Panel, NIH General Clinical Research Centers. 1989

Town and Country's List of Outstanding Medical Specialists in the United States. 1989

Landacre Society Lecturer, Ohio State University. 1988

Editorial Board, Experimental Neurology. 1988

Member, Ad Hoc Review Committee on Alzheimer Centers, NIA. 1988

Faculty Advisory Board, The Journal of the University of Rochester Medical Center. 1988 - 1990

Chair, University of Rochester, Director of Biostatistics Search Committee. 1988 - 1989

Neurologist, NIH-NINCDS Neurologic Disorders Program (HD in Venezuela). 1988 - 1994

Principal Investigator,Deprenyl & Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP), NIH-NINCDS(RO1-NS-24778). 1987 - 1995

Member, Medical Advisory Board, American Parkinson Disease Association. 1987 - 1995

Member, Education Committee, American Academy of Neurology. 1987 - 1993

Member, Program Committee, American Neurological Association. 1987 - 1989

Neurologist, NIH-NINCDS Neurologic Disorders Program (HD in Peru). 1987

Reviewer, Orphan Drug Division, FDA. 1986 - 1987

Honor Award, Huntington's Disease Foundation of America; National Huntington's Disease Association. 1986

Member, University of Rochester Committee on Tenure and Promotions (elected). 1985 - 1988

Chair, University of Rochester Clinical Research Center Advisory Committee. 1985 - 1990

Member, FDA Peripheral and Central Nervous System Drugs Advisory Committee. 1985 - 1988

Consultant, AMA Drug Evaluations. 1985 - 1986

Editorial Board, Movement Disorders. 1985 - 1992

Steering Committee, Movement Disorders. 1985 - 1988

Scientific Advisory Board, Dystonia Medical Research Foundation. 1984 - 1988

Director, Parkinson Disease Program, Watertown, NY. 1983 - 1985

Member, Scientific Program Advisory Committee, NIH, NINCDS. 1983

Member, Huntington's Disease Research Roster Advisory Committee. 1983

Editorial Board, Clinical Neuropharmacology. 1982

Principal Investigator, Baclofen As Protective Therapy in HD, NIH-NINCDS (RO1-NS-17978). 1982 - 1990

Assistant Editor, Archives of Neurology. 1982 - 1996

Member, Scientific Advisory Board, Hereditary Disease Foundation. 1982 - 1990

Consultant, Neurology Division, Bureau of Drugs, FDA. 1981 - 1985

Member, Section on Neuropharmacology, American Academy of Neurology. 1981

Neurologist, NIH-NINCDS Neurologic Disorders Program (HD in Venezuela). 1981 - 1986

National Science Council, Committee to Combat Huntington's Disease, Chairman. 1981 - 1987

Medical Advisory Board, United Parkinson Foundation. 1980 - 1994

National Science Council, Committee to Combat Huntington's Disease. 1980

Member, Huntington's Chorea Research Group, World Congress of Neurology. 1979

Medical Consultant, National Huntington's Disease Association. 1979 - 1986

Medical Consultant, Committee To Combat Huntington's Disease. 1979 - 1986

Teacher-Investigator Development Award (NS00397), NINCDS. 1978 - 1983

Fellow, Fourth Intensive Study Program, Neurosciences Research Program. 1977

Buswell Research Fellow, University of Rochester School of Medicine. 1977 - 1978

Chair, Clinical Care Work Group, U.S. Commission for the Control of Huntington's and Its Consequences. 1976 - 1977

Diploma of Recognition of Merit for Humanitarian Services (conferred by Ambassador of Bolivia to the United States). 1975

Consulting Physician, Rochester Chapter of Committee to Combat Huntington's Disease. 1975

Alpha Omega Alpha, Honor Medical Society. 1971

M.D. with Honors, University of Rochester School of Medicine. 1971

Summer Research Fellowship, University of Rochester, in Cambridge, England. 1970

American Epilepsy Foundation Fellowship. 1968

B.A. Psychology with honors, University of Pennsylvania. 1967